Company background

• News-stock chart
• Company website

Litigation background

• Cozzarelli V. Inspire Pharmaceuticals
• USDC MD North Carolina  06-00201

• Related Cases: 1:05-cv-00120-WLO
                       1:05-cv-00195-WLO-RAE
• Judge William L. Osteen
• Filed 3.01.06

Lead plaintiffs

• David and Stephanie Cozzarelli
• Robert and Carole Swoboda
• Frankfurt-Trust Investment-Gesellschaft mbH

Results of Phase III trial

• Form 8-K  2.09.05

• Press release
• Common stock sank 44.5% on announcement

Complaint

• Consolidated complaint  3.27.06

Motion to dismiss

• Motion and brief 6.30.06
• Opposition brief  8.29.06
• Company reply  10.13.06
• Company notice of supplemental authority  3.07.07
• Opposition response  3.31.07
• Opposition objection to recommendation  6.01.07
• Company response  6.18.07

Post Tellabs

• Company supplemental authority  6.27.07

Opinion

• Magistrate recommendation  5.14.07
• Recommendation: grant motion to dismiss
• Order  7.26.07
• Company' motion to dismiss is granted

• Docket No:  07-1851
• Notice of appeal  8.24.07
• 11.21.07  Opening brief - paper filing on behalf of David Cozzarelli et al entered on docket date
• 1.18.08  RESPONSE BRIEF (PAPER) file-stamped, on behalf of Inspire Pharmaceuticals Incorporated, Gregory L. Mossinghoff, Gary D. Novack and Christy L. Shaffer. Number of pages: [128]. Entered on Docket Date: 1.22.08 [997792060] [07-1851]
• 2.22.08  REPLY BRIEF (PAPER) file-stamped, on behalf of David Cozzarelli, Stephanie Cozzarelli, Frankfurt-Trust Investment Gesellschaft Mbh, Carole Swoboda and Robert Swoboda. Number of pages: [42]. Entered on Docket Date: 2.25.08. [997811604] [07-1851]

Lead plaintiff

• Milberg LLP
• Schiffrin & Barroway

Company defense

• Wilson Sonsini
• Kilpatrick Stockton

Rule 10b Private Actions